View Older Stories

May 19, 2026 07:36PM PreveCeutical Announces Extension of Non-Brokered Private Placement

May 12, 2026 05:03PM PreveCeutical closes $340,000 initial tranche of private placement

May 12, 2026 05:02PM PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement

Apr 22, 2026 03:03AM PreveCeutical announces $1 million private placement offering

Apr 22, 2026 03:00AM PreveCeutical Announces Non-Brokered Private Placement

Mar 30, 2026 03:02AM PreveCeutical Medical appoints Dr. Raj Pruthi to board of directors

Mar 30, 2026 03:00AM PreveCeutical Medical Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director

Mar 12, 2026 03:02AM BioGene Therapeutics appoints Raj Pruthi as director

Mar 12, 2026 03:00AM BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director

Feb 25, 2026 03:00AM PreveCeutical Announces Canadian Patent Office Allowance of Innovative Pain Therapy Technology

Feb 9, 2026 03:00AM PreveCeutical Announces Filing of Patent for Delivery of CNS-Active Agents

Nov 26, 2025 07:00AM PreveCeutical Medical and BioGene Therapeutics Announce Closing of Plan of Arrangement

Nov 20, 2025 12:26PM PreveCeutical Provides Clarification of News Release Announcing Update on Plan of Arrangement with BioGene Therapeutics Inc.

Nov 20, 2025 07:00AM PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.

Oct 30, 2025 07:03AM PreveCeutical closes $455,000 second tranche of private placement

Oct 30, 2025 07:00AM PreveCeutical Closes Second Tranche of Non-Brokered Private Placement

Oct 20, 2025 07:00AM PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.

Oct 10, 2025 04:02PM PreveCeutical increases private placement to $1.2 million

Oct 10, 2025 04:00PM PreveCeutical Announces Results from Annual General and Special Meeting and Increase to Size of Non-Brokered Private Placement

Sep 19, 2025 06:00PM PreveCeutical Announces Mailing and Filing of Annual General and Special Meeting Materials in Connection with a Proposed Arrangement with BioGene Therapeutics

Sep 5, 2025 05:00PM PreveCeutical closes initial tranche of private placement for $646,500

Sep 5, 2025 04:58PM PreveCeutical Closes Initial Tranche of Non-Brokered Private Placement

Sep 4, 2025 04:00PM PreveCeutical Announces Arrangement Agreement with BioGene Therapeutics

Aug 28, 2025 06:00PM PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting and Director Resignation

Aug 20, 2025 07:02AM BioGene Therapeutics names Dr. Francis Tavares as CTO

Aug 20, 2025 07:00AM BioGene Therapeutics Inc. Appoints Dr. Francis Tavares, PhD., as Chief Technology Officer

Aug 19, 2025 07:00AM BioGene Therapeutics Inc. Appoints Dr. Kamal Albarazanji as Senior Director of Metabolic Research

Jul 9, 2025 07:00AM PreveCeutical Announces Rescheduled Date for Annual General and Special Meeting

Jun 30, 2025 11:53AM PreveCeutical Welcomes Dr. Francis Tavares, PhD. As Chief Technology Officer

Jun 25, 2025 07:00AM PreveCeutical Announces Date for Annual General and Special Meeting

Jun 11, 2025 05:19PM PreveCeutical Announces Non-Brokered Private Placement

Jun 2, 2025 07:00AM PreveCeutical Welcomes Dr. Deepak Sampath, PhD. as Corporate Advisor

May 26, 2025 07:00AM PreveCeutical Welcomes Stephen Glover as Corporate Advisor

May 22, 2025 02:25PM PreveCeutical Closes Final Tranche of Up-Sized Non-Brokered Private Placement

May 14, 2025 07:00AM PreveCeutical Medical Inc. Announces Launch of New Website for BioGene Therapeutics Inc., Expanding Its Digital Presence to Enhance Accessibility and Awareness of Innovative Therapies

Apr 28, 2025 04:00PM PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement

Apr 14, 2025 09:45PM PreveCeutical Announces Up-Sized Non-Brokered Private Placement

Apr 2, 2025 07:04PM PreveCeutical Announces Update to Non-Brokered Private Placement

Mar 10, 2025 06:00PM PreveCeutical Announces Update to Private Placement

Feb 6, 2025 07:00AM PreveCeutical to Develop Sol-Gel N2B Platform for Parkinson's Disease

Feb 4, 2025 07:00AM Appointment of Dr. Bryan Jones as an Advisor to Lead Sol-Gel Special Projects

Jan 24, 2025 05:30PM PreveCeutical Announces Non-Brokered Private Placement

Jan 7, 2025 12:54PM BioGene Therapeutics to Participate in the 43rd JP Morgan Healthcare Conference

Dec 18, 2024 04:30PM PreveCeutical Announces Change of Auditors

Dec 9, 2024 07:00AM BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors

Dec 5, 2024 07:00AM BioGene Therapeutics Welcomes Ex Pfizer and Moderna Senior Leadership Dr. Barry Ticho

Dec 4, 2024 07:00AM BioGene Therapeutics Announces Appointment of Dr. Brian Gallagher, Jr. to Corporate Advisory Board

Dec 2, 2024 07:00AM BioGene Therapeutics Welcomes Stephen Glover to Its Board of Directors

Nov 25, 2024 07:00AM BioGene Therapeutics Welcomes Dr. Deepak Sampath, PhD. to Its Board of Directors

Nov 21, 2024 07:00AM BioGene Therapeutics Welcomes Professor Mirela Delibegovic, FRSE to Its Scientific Advisory Board

View Older Stories